Radiation and Chemotherapy with Ipilimumab followed by Nivolumab for Patients with Stage III Unresectable NSCLC
Clinical Trial Grant
Awarded By
H. Lee Moffitt Cancer Center & Research Institute
Start Date
May 13, 2019
End Date
June 30, 2025
Awarded By
H. Lee Moffitt Cancer Center & Research Institute
Start Date
May 13, 2019
End Date
June 30, 2025